Fernando Civeira Selected Research

Fernando Civeira Research Topics

Disease

49	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 04/2024 - 04/2002
33	Hypercholesterolemia 04/2024 - 08/2003
26	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 04/2002
21	Atherosclerosis 05/2024 - 09/2003
16	Obesity 02/2024 - 02/2009
16	Dyslipidemias (Dyslipidemia) 12/2023 - 07/2002
12	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2024 - 02/2009
12	Xanthomatosis (Xanthoma) 01/2024 - 03/2004
12	Hypertriglyceridemia 12/2023 - 02/2009
11	Type 2 Diabetes Mellitus (MODY) 02/2024 - 01/2007
10	Hyperlipidemias (Hyperlipidemia) 04/2024 - 06/2002
10	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 01/2018 - 01/2007
9	Arteriosclerosis 04/2024 - 01/2017
9	Hypertension (High Blood Pressure) 12/2022 - 04/2002
9	Insulin Resistance 08/2022 - 11/2009
8	Coronary Disease (Coronary Heart Disease) 11/2023 - 03/2004
7	Inborn Genetic Diseases (Disease, Hereditary) 12/2020 - 03/2004
6	Inflammation (Inflammations) 05/2024 - 06/2002
6	Overweight 04/2021 - 02/2009
5	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2023 - 06/2012
5	Body Weight (Weight, Body) 09/2021 - 08/2014
5	Atherosclerotic Plaque (Atheroma) 01/2020 - 01/2007
4	Injection Site Reaction 01/2019 - 11/2015
4	Homozygous Familial Hypercholesterolemia 01/2019 - 03/2015
4	Pancreatitis 01/2019 - 01/2013
3	Metabolic Diseases (Metabolic Disease) 01/2024 - 01/2018
3	Prediabetic State (Prediabetes) 04/2021 - 01/2020
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2020 - 11/2002
3	Weight Loss (Weight Reduction) 01/2020 - 08/2014
3	Myocardial Infarction 03/2019 - 01/2007
3	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2019 - 01/2018
3	Iron Overload 09/2018 - 02/2010
3	Rare Diseases (Rare Disease) 01/2018 - 01/2016
3	Diabetes Mellitus 01/2015 - 11/2008
3	Carotid Artery Diseases 07/2010 - 11/2009
2	Atrial Fibrillation 01/2023 - 12/2022
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2022 - 09/2003
2	Hyperlipoproteinemias 08/2021 - 06/2012
2	Stroke (Strokes) 01/2017 - 09/2003
2	Cholestasis 09/2014 - 09/2014

Drug/Important Bio-Agent (IBA)

42	LipidsIBA 01/2024 - 04/2002
34	LDL CholesterolIBA 11/2023 - 11/2002
21	CholesterolIBA 05/2024 - 10/2006
21	Triglycerides (Triacylglycerol)IBA 12/2023 - 11/2008
19	oxidized low density lipoproteinIBA 01/2022 - 04/2002
17	Apolipoproteins E (ApoE)IBA 04/2024 - 11/2007
14	Apolipoproteins B (ApoB)IBA 04/2024 - 10/2005
12	LDL Receptors (LDL Receptor)IBA 01/2024 - 08/2003
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2021 - 06/2014
11	Lipoproteins (Lipoprotein)IBA 04/2024 - 03/2004
11	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2003
8	ApolipoproteinsIBA 01/2023 - 11/2002
7	Lipoprotein(a)IBA 04/2024 - 07/2014
7	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 02/2009
6	HDL CholesterolIBA 01/2023 - 07/2002
6	SterolsIBA 01/2018 - 08/2014
5	Biomarkers (Surrogate Marker)IBA 05/2024 - 07/2010
5	HDL LipoproteinsIBA 11/2020 - 02/2009
4	Insulin (Novolin)FDA Link 01/2022 - 01/2015
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 09/2013
4	evolocumabIBA 09/2020 - 01/2014
4	Atorvastatin (Lipitor)FDA Link 12/2019 - 06/2002
4	IronIBA 09/2018 - 11/2009
4	Ferritins (Ferritin)IBA 09/2018 - 02/2010
4	Phytosterols (Plant Sterols)IBA 01/2016 - 05/2014
3	Thyroid HormonesIBA 02/2024 - 01/2019
3	Apolipoprotein E2IBA 01/2023 - 01/2008
3	CarbohydratesIBA 04/2021 - 01/2020
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2020 - 01/2015
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2019 - 07/2010
3	PCSK9 InhibitorsIBA 05/2019 - 08/2017
3	NucleotidesIBA 01/2019 - 11/2017
3	Apolipoprotein B-100 (Apo B 100)IBA 01/2019 - 11/2002
3	ProteomeIBA 06/2014 - 11/2009
2	Blood Glucose (Blood Sugar)IBA 09/2023 - 10/2020
2	ORALIT (ORS)IBA 01/2023 - 01/2015
2	27-hydroxycholesterolIBA 01/2022 - 04/2014
2	24-hydroxycholesterolIBA 01/2022 - 04/2014
2	OxysterolsIBA 01/2022 - 04/2014
2	maltodextrinIBA 04/2021 - 01/2020
2	MaltoseIBA 04/2021 - 01/2020
2	isomaltulose (palatinose)IBA 04/2021 - 01/2020
2	DextrinsIBA 04/2021 - 01/2020
2	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 04/2014
2	Antihypertensive Agents (Antihypertensives)IBA 10/2020 - 03/2020
2	CalciumIBA 01/2020 - 03/2016
2	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 11/2019 - 07/2002
2	Proprotein Convertase 9IBA 01/2019 - 12/2016
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2019 - 07/2018
2	MicroRNAs (MicroRNA)IBA 01/2017 - 07/2016
2	alirocumabIBA 01/2016 - 11/2015
2	Ezetimibe (Zetia)FDA Link 01/2016 - 01/2012
2	Phospholipids (Phosphatides)FDA LinkGeneric 09/2013 - 07/2010
2	AntioxidantsIBA 09/2012 - 07/2012
2	Messenger RNA (mRNA)IBA 09/2011 - 11/2007
2	CytokinesIBA 09/2011 - 06/2009

Therapy/Procedure

14	Therapeutics 01/2022 - 06/2014
2	Secondary Prevention 11/2022 - 08/2020
2	Glycemic Control 08/2022 - 01/2020
2	Mediterranean Diet 05/2018 - 11/2017